日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies

AFM11治疗B细胞恶性肿瘤患者的安全性:两项1期研究的结果

Topp, Max; Dlugosz-Danecka, Monika; Skotnicki, Aleksander B; Salogub, Galina; Viardot, Andreas; Klein, Andreas K; Hess, Georg; Michel, Christian S; Grosicki, Sebastian; Gural, Alex; Schwarz, Sylvia E; Pietzko, Kerstin; Gärtner, Ulrike; Strassz, András; Alland, Leila; Mayer, Jiri

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

一项针对复发或难治性霍奇金淋巴瘤患者的 AFM13 联合帕博利珠单抗的 1b 期研究

Bartlett, Nancy L; Herrera, Alex F; Domingo-Domenech, Eva; Mehta, Amitkumar; Forero-Torres, Andres; Garcia-Sanz, Ramon; Armand, Philippe; Devata, Sumana; Izquierdo, Antonia Rodriguez; Lossos, Izidore S; Reeder, Craig; Sher, Taimur; Chen, Robert; Schwarz, Sylvia E; Alland, Leila; Strassz, Andras; Prier, Kim; Choe-Juliak, Cassandra; Ansell, Stephen M